BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25394173)

  • 1. Reporting genomic secondary findings: ACMG members weigh in.
    Scheuner MT; Peredo J; Benkendorf J; Bowdish B; Feldman G; Fleisher L; Mulvihill JJ; Watson M; Herman GE; Evans J
    Genet Med; 2015 Jan; 17(1):27-35. PubMed ID: 25394173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.
    Hart MR; Biesecker BB; Blout CL; Christensen KD; Amendola LM; Bergstrom KL; Biswas S; Bowling KM; Brothers KB; Conlin LK; Cooper GM; Dulik MC; East KM; Everett JN; Finnila CR; Ghazani AA; Gilmore MJ; Goddard KAB; Jarvik GP; Johnston JJ; Kauffman TL; Kelley WV; Krier JB; Lewis KL; McGuire AL; McMullen C; Ou J; Plon SE; Rehm HL; Richards CS; Romasko EJ; Miren Sagardia A; Spinner NB; Thompson ML; Turbitt E; Vassy JL; Wilfond BS; Veenstra DL; Berg JS; Green RC; Biesecker LG; Hindorff LA
    Genet Med; 2019 May; 21(5):1100-1110. PubMed ID: 30287922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Professionals' Attitudes about Secondary Findings in Genomic Sequencing of Children.
    Barajas M; Ross LF
    J Pediatr; 2015 May; 166(5):1276-1282.e7. PubMed ID: 25726921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
    Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
    Genet Med; 2022 Jul; 24(7):1407-1414. PubMed ID: 35802134
    [No Abstract]   [Full Text] [Related]  

  • 5. Reporting Incidental Findings in Clinical Whole Exome Sequencing: Incorporation of the 2013 ACMG Recommendations into Current Practices of Genetic Counseling.
    Smith LA; Douglas J; Braxton AA; Kramer K
    J Genet Couns; 2015 Aug; 24(4):654-62. PubMed ID: 25403901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
    Hershberger RE; Givertz MM; Ho CY; Judge DP; Kantor PF; McBride KL; Morales A; Taylor MRG; Vatta M; Ware SM;
    Genet Med; 2018 Sep; 20(9):899-909. PubMed ID: 29904160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
    Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
    Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.
    Ackerman SL; Koenig BA
    AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current controversies in prenatal diagnosis 2: The 59 genes ACMG recommends reporting as secondary findings when sequencing postnatally should be reported when detected on fetal (and parental) sequencing.
    Amor DJ; Chitty LS; Van den Veyver IB
    Prenat Diagn; 2020 Dec; 40(12):1508-1514. PubMed ID: 32091628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mainstreaming informed consent for genomic sequencing: A call for action.
    Bunnik EM; Dondorp WJ; Bredenoord AL; de Wert G; Cornel MC
    Eur J Cancer; 2021 May; 148():405-410. PubMed ID: 33784533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Position statement on opportunistic genomic screening from the Association of Genetic Nurses and Counsellors (UK and Ireland).
    Middleton A; Patch C; Wiggins J; Barnes K; Crawford G; Benjamin C; Bruce A;
    Eur J Hum Genet; 2014 Aug; 22(8):955-6. PubMed ID: 24398792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing.
    Evans BJ
    Genet Med; 2013 Dec; 15(12):915-20. PubMed ID: 24030435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary findings: How did we get here, and where are we going?
    Ormond KE; O'Daniel JM; Kalia SS
    J Genet Couns; 2019 Apr; 28(2):326-333. PubMed ID: 30821867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives of clinical genetics professionals toward genome sequencing and incidental findings: a survey study.
    Lemke AA; Bick D; Dimmock D; Simpson P; Veith R
    Clin Genet; 2013 Sep; 84(3):230-6. PubMed ID: 23163796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes.
    Jang MA; Lee SH; Kim N; Ki CS
    Genet Med; 2015 Dec; 17(12):1007-11. PubMed ID: 25856671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informed consent for return of incidental findings in genomic research.
    Appelbaum PS; Waldman CR; Fyer A; Klitzman R; Parens E; Martinez J; Price WN; Chung WK
    Genet Med; 2014 May; 16(5):367-73. PubMed ID: 24158054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs).
    Ploug T; Holm S
    PLoS One; 2017; 12(7):e0179935. PubMed ID: 28671958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the justifiability of ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
    May T
    J Law Med Ethics; 2015; 43(1):134-42. PubMed ID: 25846044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
    ACMG Board of Directors
    Genet Med; 2019 Jul; 21(7):1467-1468. PubMed ID: 31019278
    [No Abstract]   [Full Text] [Related]  

  • 20. The preferences of potential stakeholders in psychiatric genomic research regarding consent procedures and information delivery.
    Sundby A; Boolsen MW; Burgdorf KS; Ullum H; Hansen TF; Middleton A; Mors O
    Eur Psychiatry; 2019 Jan; 55():29-35. PubMed ID: 30384109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.